Analgesic Effect of Superficial Cervical Plexus Block in Postoperative Neck Surgeries

NCT07539935 | Active Not Recruiting Phase 4 FDA Drug

• 1 other identifier: Soh_Med_26_3_13MS
• Study Type: interventional
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

analgesic effect of superficial cervical plexus block by using ultrasound in patients undergoing neck surgeries

Conditions

Postoperative Pain

Outcome Measures

Primary Outcomes (1)

• Analgesic effect of bilateral superficial cervical plexus block in postoperative neck surgeries

  To assess the analgesic efficacy of bilateral superficial cervical plexus block on postoperative pain following neck surgery, as measured by the Visual Analog Scale Pain was assessed using the Visual Analog Scale (VAS; 0 = no pain, 10 = worst imaginable pain) at 1, 4, 8, 12, and 24 hours postoperatively.

  within the first 24 hours postoperatively

Secondary Outcomes (1)

• Total opioid consumption

  within the first 24 hours postoperatively

Other Outcomes (2)

• Nausea and vomiting

  24 hours postoperative

• patients satisfaction score

  at 24 hours postoperatively

Study Arms (2)

Group will take the block

ACTIVE COMPARATOR

Procedure: superficial cervical plexus block guided by ultrasound with bupivacaine

Controlled group

PLACEBO COMPARATOR

Drug: Paracetamol (500 mg) tablets

Interventions

superficial cervical plexus block guided by ultrasound with bupivacaine PROCEDURE

in active group we will use bupivacaine in superficial cervical plexus block to deal with pain postoperative neck surgeries

Group will take the block

Paracetamol (500 mg) tablets DRUG

controlled group will take shame block with normal saline and paracetamol only

Controlled group

Eligibility Criteria

• Age: 18 Years - 60 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• The study include all patients between 18 and 60 years of age who underwent elective neck surgery under general anesthesia

You may not qualify if:

• \. Patient refusal . 2. Patient with significant neurological , psychological disease . 3. patient known allergy to local anesthesia . 4. Patient uncorrected coagulapathy or anticoagulant therapy . 5. Patient with sever neck deformity . 6. Patient with infection at site of injection . 7. Patient with sever respiratory disease . 8. patients with regular use of analgesic medications

Sponsors & Collaborators

• Sohag University: lead

Study Sites (1)

Faculty of medicine, Sohag University.

Sohag, Egypt

Location

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Bupivacaine; Acetaminophen

Condition Hierarchy (Ancestors)

Postoperative Complications; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Pain; Neurologic Manifestations; Signs and Symptoms

Intervention Hierarchy (Ancestors)

Anilides; Amides; Organic Chemicals; Aniline Compounds; Amines; Acetanilides

Study Design

• Study Type: interventional
• Phase: phase 4
• Allocation: RANDOMIZED
• Masking: TRIPLE
• Who Masked: PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
• Purpose: TREATMENT
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Resident of Anesthesia, Intensive Care and Pain management Sohag university hospital.

Study Record Dates

• First Submitted: April 1, 2026
• First Posted: April 20, 2026
• Study Start: March 16, 2026
• Primary Completion (Estimated): March 30, 2027
• Study Completion (Estimated): October 30, 2027
• Last Updated: April 23, 2026

Record last verified: 2026-04

Locations

EG (1)